- Home
- TLN vs TECH Comparison
TLN vs TECH Comparison
Compare TLN & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLN
- TECH
- Stock Information
- Founded
- TLN 2015
- TECH 1976
- Country
- TLN United States
- TECH United States
- Employees
- TLN N/A
- TECH N/A
- Industry
- TLN Electric Utilities: Central
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLN Utilities
- TECH Health Care
- Exchange
- TLN Nasdaq
- TECH Nasdaq
- Market Cap
- TLN 9.7B
- TECH 7.8B
- IPO Year
- TLN N/A
- TECH 1989
- Fundamental
- Price
- TLN $288.66
- TECH $49.89
- Analyst Decision
- TLN Strong Buy
- TECH Buy
- Analyst Count
- TLN 12
- TECH 11
- Target Price
- TLN $247.42
- TECH $72.00
- AVG Volume (30 Days)
- TLN 965.8K
- TECH 2.5M
- Earning Date
- TLN 08-12-2025
- TECH 08-06-2025
- Dividend Yield
- TLN N/A
- TECH 0.64%
- EPS Growth
- TLN 50.75
- TECH N/A
- EPS
- TLN 10.79
- TECH 0.83
- Revenue
- TLN $2,087,000,000.00
- TECH $1,208,770,000.00
- Revenue This Year
- TLN $9.94
- TECH $7.07
- Revenue Next Year
- TLN $23.87
- TECH $5.88
- P/E Ratio
- TLN $26.78
- TECH $60.23
- Revenue Growth
- TLN N/A
- TECH 4.72
- 52 Week Low
- TLN $98.50
- TECH $46.01
- 52 Week High
- TLN $294.46
- TECH $83.62
- Technical
- Relative Strength Index (RSI)
- TLN 78.68
- TECH 49.63
- Support Level
- TLN $246.95
- TECH $49.05
- Resistance Level
- TLN $294.46
- TECH $51.66
- Average True Range (ATR)
- TLN 10.37
- TECH 1.59
- MACD
- TLN 2.26
- TECH 0.17
- Stochastic Oscillator
- TLN 89.17
- TECH 47.40
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.